News
Newly published research further validates GlucoModicum’s path to high-precision, non-invasive glucose monitor
Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor
FIMEA Authorizes GlucoModicum to Conduct Pre-Pivotal Clinical Investigation Under EU MDR Article 62
Eurofins Electric & Electronics Finland audits GlucoModicum-Sofio operations, with zero deviations.
GlucoModicum Completes Clinical Performance Study of 646 Subject Visits and Reports Positive Results for Its Sofio Needle-Free Glucose Monitor
Major Medical Device Development Program Conducted with Phillips-Medisize Across the US and Europe to Advance Sofio
Newly published research further validates GlucoModicum’s path to high-precision, non-invasive glucose monitor
Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor
FIMEA Authorizes GlucoModicum to Conduct Pre-Pivotal Clinical Investigation Under EU MDR Article 62
Eurofins Electric & Electronics Finland audits GlucoModicum-Sofio operations, with zero deviations.
GlucoModicum Completes Clinical Performance Study of 646 Subject Visits and Reports Positive Results for Its Sofio Needle-Free Glucose Monitor
Major Medical Device Development Program Conducted with Phillips-Medisize Across the US and Europe to Advance Sofio